Further down-regulated levels of NF-κB p65, p-IKKβ, and p-IκBα, and enhanced expression of ZO-1 and occludin in colon tissue indicated that the EPS alleviated IBD by suppressing the NF-κB signaling pathway. The gene discussed is OCLN; the disease is inflammatory bowel disease.